Brian Goff insider trades

Open-market stock purchases and sales by Brian Goff, Chief Executive Officer at Agios Pharmaceuticals, Inc, from SEC Form 4 filings since Jul 1, 2015.

Recent trades

DateStockTradeValue
Jun 18, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Jun 18, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Jun 9, 2026NTLA Intellia Therapeutics, IncBought (not open market)—
Jun 9, 2026NTLA Intellia Therapeutics, IncBought (not open market)—
Apr 2, 2026AGIO Agios Pharmaceuticals, IncSold$433K
Apr 2, 2026AGIO Agios Pharmaceuticals, IncSold$229K
Apr 2, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Apr 2, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Mar 2, 2026AGIO Agios Pharmaceuticals, IncSold$112K
Mar 2, 2026AGIO Agios Pharmaceuticals, IncSold$239K
Mar 2, 2026AGIO Agios Pharmaceuticals, IncSold$171K
Mar 2, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Mar 2, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Mar 2, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Mar 1, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Mar 1, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Dec 30, 2025AGIO Agios Pharmaceuticals, IncSold$169K
Dec 30, 2025AGIO Agios Pharmaceuticals, IncSold$338K
Dec 30, 2025AGIO Agios Pharmaceuticals, IncBought (not open market)—
Dec 30, 2025AGIO Agios Pharmaceuticals, IncBought (not open market)—

Companies traded

  • AGIO Agios Pharmaceuticals, Inc: 19 sales, last Jun 18, 2026
  • NTLA Intellia Therapeutics, Inc: other filings, last Jun 9, 2026
  • ALXN Alexion Pharmaceuticals, Inc: 2 sales, last Jul 21, 2021
  • BXLT Baxalta Inc: other filings, last Jun 3, 2016

Get free alerts when Brian Goff files a new trade →